DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 07 · Volume 44 · November 2011 DOI: 10.1055/s-002-22437

Original Paper

317
Paulzen, M.; Finkelmeyer, A.; Grözinger, M.: Augmentative Effects of Fluvoxamine on Duloxetine Plasma Levels in Depressed Patients
324
Neuner, T.; Hübner-Liebermann, B.; Haen, E.; Hausner, H.; Felber, W.; Wittmann, M.; for AGATE: Completed Suicides in 47 Psychiatric Hospitals in Germany – Results from the AGATE-Study
331
Franke, A. G.; Christmann, M.; Bonertz, C.; Fellgiebel, A.; Huss, M.; Lieb, K.: Use of Coffee, Caffeinated Drinks and Caffeine Tablets for Cognitive Enhancement in Pupils and Students in Germany
339
Häßler, F.; Glaser, T.; Reis, O.: Effects of Zuclopenthixol on Aggressive Disruptive Behavior in Adults with Mental Retardation – A 2-Year Follow-Up on a Withdrawal Study

Erratum

343
Schoemaker, J.; Naber, D.; Vrijland, P.; Panagides, J.; Emsley, R.: Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder

Letter

344
Dersch, R.; Zwernemann, S.; Voderholzer, U.: Partial Status Epilepticus after Electroconvulsive Therapy and Medical Treatment with Bupropion
346
Kobayashi, T.; Saito, N.; Suda, S.; Shioda, K.; Kato, S.: Pharmacoresistant Convulsions and Visual Hallucinations around Two Weeks after Selegiline Overdose: A Case Report
347
Liang, C.-S.; Yang, F.-W.; Liao, W.-C.: An Unusual Presentation of Catatonia in a Patient with Schizoaffective Disorder